BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 16691623)

  • 1. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
    Crompton BD; Goldsby RE; Weinberg VK; Feren R; O'Donnell RJ; Ablin AR
    Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
    Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
    Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
    Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcome after local recurrence of osteosarcoma.
    Grimer RJ; Sommerville S; Warnock D; Carter S; Tillman R; Abudu A; Spooner D
    Eur J Cancer; 2005 Mar; 41(4):578-83. PubMed ID: 15737563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
    Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS; Arndt CA
    Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
    J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
    Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
    Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
    Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
    Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.